New search | Conferencedetail
mail
Print view
 
 

Gene Therapy for Muscular Disorders

Evvnt Promotion / evvnt
Archive
-
25.05.2021 - 27.05.2021  Online
Time: 08:00 to 17:00
 
Conference themes
With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and navigating toxicity to develop truly safe and transformative therapeutics for muscular disorders patients.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/727634-0?pid=4832

Speakers: Michael O'Callaghan, Senior Vice President, Translational Medicine, AskBio, Michael Roberts, Chief Technology Officer, AskBio Europe, and more.
 

Enquiries and Registration:

https://go.evvnt.com/727634-1?pid=4832
Mr. Ellie Saunders
 
Categories
General Medicine
Languages
English
Congress fees
USD 1199.00 to USD 2696.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHilfswerk AustrianewTreeÄrzte der WeltAnästhesie in Entwicklungsländern e. V.Charité International AcademyHelix - Forschung & Beratung Wien